Today's Daily Dose brings you news about FDA approval of Bausch Health's acne drug; licensing deal between Catalyst Biosciences and Biogen; disappointing MDD trial results of Minerva and Urogen's upcoming regulatory catalyst.
from RTT - Biotech https://ift.tt/2Ey0WGH
via IFTTT
No comments:
Post a Comment